| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 03/19/2003 | CN1103217C Aqueous eye drops containing apafant as active ingredient |
| 03/18/2003 | US6534520 Antiviral compounds |
| 03/18/2003 | US6534491 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 03/13/2003 | WO2003020730A1 4-thioxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carbothioamides as antiviral agents |
| 03/13/2003 | WO2003020729A1 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOXAMIDES AS ANT IVIRAL AGENTS |
| 03/13/2003 | WO2003020728A1 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS |
| 03/13/2003 | WO2003020727A1 GLYCINE-SUBSTITUTED THIENO [2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY |
| 03/13/2003 | WO2003020726A1 Thieno[2,3-d]pyrimidines with combined lh and fsh agonistic activity |
| 03/13/2003 | WO2003020700A2 SUBSTITUTED INDENO[1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF |
| 03/13/2003 | WO2003020264A1 Remedial agent for cancer and cancer preventive |
| 03/13/2003 | WO2002096359A3 Piperazine pentanamide hiv protease inhibitors |
| 03/13/2003 | WO2002076950A3 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors |
| 03/13/2003 | WO2002066469A3 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
| 03/13/2003 | US20030050320 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity |
| 03/13/2003 | US20030047719 For use as semiconductors or charge transport materials in optical, electrooptical or electronic devices including field effect transistors, electroluminescent, photovoltaics, sensors and electrophotographic recording devices |
| 03/13/2003 | CA2457534A1 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 03/13/2003 | CA2452438A1 4-thioxo-4,7-dihydro-thieno¬2,3-b|pyridine-5-carbothioamides as antiviral agents |
| 03/13/2003 | CA2452431A1 4-thioxo-4,7-dihydro-thieno¬2,3-b|pyridine-5-carboxamides as antiviral agents |
| 03/12/2003 | EP1291023A1 Sustained release compositions |
| 03/12/2003 | EP1289985A2 Beta-carboline derivatives useful as inhibitors of phosphodiesterase |
| 03/12/2003 | EP1289980A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides |
| 03/12/2003 | EP1289563A2 Biotin derivatives |
| 03/12/2003 | EP1289525A2 Tricyclic pyrazole derivatives as protein kinase inhibitors |
| 03/11/2003 | US6531604 Useful as medicines having an osteogenesis promoting effect and chondrogensis promoting effect. |
| 03/06/2003 | WO2003018590A1 Process for producing thienopyridine derivative |
| 03/06/2003 | WO2003018548A2 Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof |
| 03/06/2003 | WO2003018012A1 Preventive agent/remedial agent for constipation predominant ibs |
| 03/06/2003 | WO2003018002A2 Cyclopropyl and cyclobutyl epothilone analogs |
| 03/06/2003 | WO2002042427A3 Mass tags for quantitative analysis |
| 03/06/2003 | US20030045540 Nicotinic acetylcholine receptors antagonists; central nervous system disorder treatments |
| 03/06/2003 | US20030045516 Chemokine receptor antagonists and methods of use therefor |
| 03/06/2003 | US20030045432 Phenyl-substituted cyclic ketoenols |
| 03/06/2003 | US20030044399 Method of treatment |
| 03/06/2003 | CA2456280A1 Cyclopropyl and cyclobutyl epothilone analogs |
| 03/05/2003 | EP1288206A1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
| 03/05/2003 | EP1288203A1 Cyclic nitrones and pharmaceutical compositions containing them |
| 03/05/2003 | EP1287001A1 Thiophene derivatives useful as anticancer agents |
| 03/05/2003 | EP1286994A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 03/05/2003 | EP1286973A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists |
| 03/05/2003 | EP1286673A2 Ligands of integrin receptors |
| 03/05/2003 | EP1185534B1 Benzopyrans annelated in c7-c8 with an aromatic heterocycle and compositions and (co)polymer matrices containing them |
| 03/05/2003 | EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS |
| 03/05/2003 | EP0792273B1 Bicyclic oxazine and thiazine oxazolidinone antibacterials |
| 03/05/2003 | EP0690863B1 Tetracyclic compounds as dopamine agonists |
| 03/05/2003 | CN1400969A Fused imidazolium derivatives |
| 03/05/2003 | CN1102594C Agent for suppressing interferencein immuno assaying |
| 03/04/2003 | US6528662 Process for the preparation of 3, 4-alkylenedioxythiophene-2,5-dicarboxylic acid derivatives |
| 03/04/2003 | US6528653 Thienopyrrolidinones |
| 03/04/2003 | US6528627 Bridged aromatic substituted amine ligands with donor atoms |
| 02/27/2003 | WO2003016316A1 Diazacycloalkanes as oxytocin agonists |
| 02/27/2003 | WO2003016302A1 Diamine derivatives |
| 02/27/2003 | WO2003016248A2 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace) |
| 02/27/2003 | WO2002100862A3 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 02/27/2003 | WO2002100851A3 Thiophene derivatives as antiviral agents for flavivirus infection |
| 02/27/2003 | US20030040631 As chemical intermediates used for the preparation of S-alpha-ethyl-2-oxo-1-pyrrolidine acetamide |
| 02/27/2003 | US20030040521 For controlling and preventing pests |
| 02/27/2003 | CA2456841A1 Cyclohexyl and piperidine diamine derivatives useful as activated blood coagulation factor x inhibitors |
| 02/27/2003 | CA2453962A1 Diazacycloalkanes as oxytocin agonists |
| 02/26/2003 | EP1284977A1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 02/26/2003 | EP1011726B1 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents |
| 02/26/2003 | EP0920431B1 Thienopyrimidines |
| 02/26/2003 | CN1102144C Noval pyrimidine derivatives and prepn. processes thereof |
| 02/25/2003 | US6525215 HIV protease inhibitors |
| 02/25/2003 | US6525193 Aminoaryl oxazolidinone N-oxides |
| 02/25/2003 | US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists |
| 02/25/2003 | US6525042 Sulfonyl derivatives |
| 02/25/2003 | US6525025 Controlling apoptosis; cardiovascular disorders; central nervous system disorders |
| 02/20/2003 | WO2003013655A2 Carbonic anhydrase inhibitors |
| 02/20/2003 | WO2003013522A1 Preventives/remedies for cholinergic neuropathy |
| 02/20/2003 | WO2002072585A3 Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 02/20/2003 | WO2002068399B1 Aryl carbamate derivatives, preparation and use thereof |
| 02/20/2003 | WO2002030860A9 Ketone compounds and compositions for cholesterol management and related uses |
| 02/20/2003 | US20030036612 Containing a ligand such as (3-methyl-4-trimethylsilyl-1-cyclopentadienyl)-7-(2,5-dimethyl -cyclopenta(1,2-b:4,3-b')-dithiophene)dimethylsilane |
| 02/20/2003 | US20030036603 E.g., spiro(7-oxa-5-norbornene-2,3'- succinic anhydride, -tetrahydrofuran-2'-one, and -(2',2'-dimethyl)tetrahydrofuran)) |
| 02/20/2003 | US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease. |
| 02/20/2003 | CA2456939A1 Carbonic anhydrase inhibitors |
| 02/20/2003 | CA2456594A1 Preventives/remedies for cholinergic neuropathy |
| 02/19/2003 | EP1119571B1 Tricyclic delta3-piperidines as alpha2-antagonists |
| 02/19/2003 | EP0971931B1 Method for debenzylation of dibenzyl biotin |
| 02/19/2003 | EP0799218B1 Diaryl-2-(5h)-furanones as cox-2 inhibitors |
| 02/19/2003 | CN1101820C Method for debenzylation of dibenzyl biotin |
| 02/19/2003 | CN1101680C Use of thienotriazolodia zepine to increase apolipoprotein A-I levels |
| 02/18/2003 | US6521622 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 02/18/2003 | US6521620 Suppressing tumors, especially breast cancers; antiproli-ferative agents; arthritis, vascular restenosis, psoriasis and angiogenesis; extremely low cytotoxicity |
| 02/13/2003 | WO2003011872A1 Platelet adp receptor inhibitors |
| 02/13/2003 | WO2003011869A1 Radioligands and their use for identifying potassium channel modulators |
| 02/13/2003 | WO2003011868A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 02/13/2003 | WO2003011858A1 Substituted isoindoles and e use thereof |
| 02/13/2003 | US20030032652 Hydroxamic and carboxylic acid derivatives |
| 02/13/2003 | CA2468925A1 Platelet adp receptor inhibitors |
| 02/13/2003 | CA2455772A1 Substituted isoindoles and their use |
| 02/13/2003 | CA2453274A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 02/12/2003 | EP0937078B1 Tricyclic carbapenem compounds |
| 02/12/2003 | EP0926146B1 Chromene compounds |
| 02/11/2003 | US6518427 Compounds are exceedingly water soluble which is useful in preparing pharmaceutical formulations of these compounds. They are also rapidly converted back to the parent amines in vivo, making them useful as prodrugs of the parent amines. |
| 02/11/2003 | US6518286 Compounds |
| 02/11/2003 | US6518267 Protease inhibitors |
| 02/11/2003 | US6518265 1H-imidazopyridine derivatives |
| 02/11/2003 | CA2205274C Novel 2,3 disubstituted-(5,6)-heteroarylfused-pyrimidine-4-ones |
| 02/06/2003 | WO2003009852A1 Tyrosine kinase inhibitors |